StonvexLoading…
StonvexStonvexStonvexCore line items from INVU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $36.26M | $52.38M | $67.92M | $61.85M |
Operating Income | $-8.26M | $1.69M | $4.60M | $-8.61M |
Net Income | $-8.91M | $1.19M | $2.83M | $-12.94M |
EPS (Diluted) | $-0.01 | $0.00 | $0.00 | $-0.01 |
Total Assets | $21.50M | $31.57M | $33.69M | $35.58M |
Total Liabilities | $12.57M | $14.37M | $14.90M | $18.20M |
Cash & Equivalents | $9.99M | $22.47M | $20.91M | $20.32M |
Free Cash Flow OCF − CapEx | $-4.24M | $13.54M | $3.50M | $-5.91M |
Shares Outstanding | 1.85B | 1.86B | 2.33B | 2.64B |